Aspirin/Rosuvastatin Zinc

阿司匹林/瑞舒伐他汀锌

Report date: 2025/02/07 11:48:34

Base Information

Drug NameAspirin/Rosuvastatin Zinc
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsHMG-CoA reductase inhibitors
TargetsCyclooxygenasesHMG-CoA reductase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsYes AspirinRosuvastatin Zinc
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesEgis Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEgis Pharmaceuticals PLC
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeC10BX
Related LinksN/A